Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Appointed director
|
|
Skye Bioscience, Inc. (NMUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
4
| Schwab Andrew J. (10% Owner) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 267,602,039 shares
@ $0
Granted 10,558,878 shares
@ $0
Granted 684,361,447 shares
@ $0.0103, valued at
$7M
Granted 161,944,872 shares
@ $0.0103, valued at
$1.7M
Granted 6,389,921 shares
@ $0.0103, valued at
$65.8k
Granted 426,348,120 warrants
@ $0.0206, valued at
$8.8M
|
|
| 08/22/2023 |
3
| Schwab Andrew J. (10% Owner) has filed a Form 3 on Skye Bioscience, Inc. |
| 08/22/2023 |
3
| Grayson Paul A. (Director) has filed a Form 3 on Skye Bioscience, Inc. |
| 03/17/2023 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 16,641,486 shares
@ $0.017, valued at
$282.9k
Granted 41,379,164 shares
@ $0.0386, valued at
$1.6M
Acquired 9,141,486 warrants
@ $0.151, valued at
$1.4M
Disposed/sold 9,141,486 warrants
@ $0.017, valued at
$155.4k
Bought 2,500,000 options to buy
@ $0.0386, valued at
$96.5k
Disposed/sold 2,500,000 options to buy
@ $0.0386, valued at
$96.5k
|
|
| 01/09/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.017, valued at
$4.3k
|
|
| 11/15/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2021 |
4
| DHILLON PUNIT (CEO) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 2,000,000 shares
@ $0
Granted 3,090,000 options to buy
@ $0.058, valued at
$179.2k
|
|
| 12/16/2021 |
4
| Arsenault Kaitlyn Melanie (CFO) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 1,000,000 shares
@ $0
Granted 1,770,000 options to buy
@ $0.058, valued at
$102.7k
|
|
| 12/16/2021 |
4
| Ward Keith Wayne (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.058, valued at
$14.5k
|
|
| 12/16/2021 |
3
| Ward Keith Wayne (Director) has filed a Form 3 on Skye Bioscience, Inc. |
| 10/05/2021 |
4
| Arsenault Kaitlyn Melanie (CFO) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 1,600,000 options to buy
@ $0.09, valued at
$144k
|
|
| 10/05/2021 |
3
| Arsenault Kaitlyn Melanie (CFO) has filed a Form 3 on Skye Bioscience, Inc. |
| 09/16/2021 |
4
| DALESANDRO MARGARET (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.12, valued at
$18k
|
|
| 09/16/2021 |
4
| HEPPELL JAMES L (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.12, valued at
$18k
|
|
| 09/16/2021 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.12, valued at
$3k
|
|
| 10/07/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/13/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/12/2020 |
4
| DALESANDRO MARGARET (Director) has filed a Form 4 on Emerald Bioscience, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.045, valued at
$11.3k
|
|
| 08/12/2020 |
3
| DALESANDRO MARGARET (Director) has filed a Form 3 on Emerald Bioscience, Inc. |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| HEPPELL JAMES L (Director) has filed a Form 4 on Emerald Bioscience, Inc.|
Txns:
| Bought 500,000 shares
@ $50000, valued at
$25000M
Granted 1,000,000 options to buy
@ $0.045, valued at
$45k
|
|
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/28/2020 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Emerald Bioscience, Inc.|
Txns:
| Acquired 40,800,000 shares
@ $4080000, valued at
$166464000M
Disposed of 40,800,000 options to buy
@ $0.1, valued at
$4.1M
Disposed of 4,080,000 options to buy
@ $0.4, valued at
$1.6M
|
|
| 08/23/2019 |
4
| KIM DENNIS D (Chief Medical Officer) has filed a Form 4 on Emerald Bioscience, Inc.|
Txns:
| Granted 736,541 options to buy
@ $0.3, valued at
$221k
|
|
|
|
|